Nehemia Ngetich Appointed as Acting CEO of The National Biosafety Authority (NBA) Following the Suspension of Roy Mugiira
Position
Chief Executive Officer
Company
The National Biosafety Authority (NBA)
Description
Nehemia Ngetich has been appointed as the acting CEO of The National Biosafety Authority (NBA) following the suspension of Roy Mugiira. Mugiira has been suspended for a period of three months due to alleged financial impropriety at the Authority.
Quick answer
Nehemia Ngetich Appointed as Acting CEO of The National Biosafety Authority (NBA) Following the Suspension of Roy Mugiira (July 8, 2024). The National Biosafety Authority (NBA) is based in Nairobi, Nairobi County, Kenya.
- Who is the new Chief Executive Officer at The National Biosafety Authority (NBA)?
- The National Biosafety Authority (NBA) named Nehemia Ngetich Chief Executive Officer, announced July 8, 2024.
- What did The National Biosafety Authority (NBA) announce on July 8, 2024?
- Nehemia Ngetich has been appointed as the acting CEO of The National Biosafety Authority (NBA) following the suspension of Roy Mugiira. Mugiira has been suspended for a period of three months due to alleged financial impropriety at the Authority.
- What does The National Biosafety Authority (NBA) do?
- The National Biosafety Authority (NBA) was established by the Biosafety Act No. 2 of 2009 to exercise general supervision and control over the transfer, handling and use of genetically modified organisms (GMOs).
- Where is The National Biosafety Authority (NBA) based?
- The National Biosafety Authority (NBA) is based in Nairobi, Nairobi County, Kenya.
- Which similar companies made leadership changes around the same time?
- AbbVie Inc. (July 10, 2024), American Osteopathic Association (July 25, 2024), Accelerated Cure Project (July 31, 2024) and Meadows Behavioral Healthcare (June 11, 2024) also announced leadership changes within 45 days of The National Biosafety Authority (NBA).
Source: Fundz verified event record.
Other recent leadership changes in Non Profit and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- AbbVie Appoints Roopal Thakkar, M.D. as Executive Vice President, R&D and Chief Scientific Officer (July 10, 2024)
- Teresa A. Hubka Installed as President of the American Osteopathic Association (AOA) (July 25, 2024)
- Accelerated Cure Project (ACP) Appoints Stephanie Buxhoeveden as Chief Scientific Officer (CSO) (July 31, 2024)
- Jaime Vinck, MC, LPC, Named President at Meadows Behavioral Healthcare (June 11, 2024)
- Steven R. Meyers, PhD, Appointed as Chief Executive Officer of the American Institute of Ultrasound in Medicine (AIUM) (August 6, 2024)
- American Oncology Network Appoints David Afshar as Chief Financial and Operating Officer (June 3, 2024)
Who to call at The National Biosafety Authority (NBA), and when
A new leader at The National Biosafety Authority (NBA) brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day The National Biosafety Authority (NBA) raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at The National Biosafety Authority (NBA), from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at The National Biosafety Authority (NBA). With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment The National Biosafety Authority (NBA) changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
The National Biosafety Authority (NBA) changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.